JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Neurology, Neurosurgery, and Psychiatry 2007;78:539-541; doi:10.1136/jnnp.2006.096388
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baguley, I. J
Right arrow Articles by Cameron, I. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baguley, I. J
Right arrow Articles by Cameron, I. D

SHORT REPORT

Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series

Ian J Baguley1, Roxana E Heriseanu1, Joseph A Gurka1, Annette Nordenbo2, Ian D Cameron3

1 Brain Injury Rehabilitation Service, Westmead Hospital, Westmead NSW, Australia
2 Brain Injury Unit, Hvidovre University Hospital, Hvidovre, Denmark
3 Rehabilitation Studies Unit, University of Sydney, Sydney, Australia

Correspondence to:
Correspondence to:
Dr Ian J Baguley
Brain Injury Rehabilitation Service, Westmead Hospital, PO Box 533, Wentworthville NSW 2145, Australia; ianb{at}biru.wsahs.nsw.gov.au


ABSTRACT
The pharmacological management of dysautonomia, otherwise known as autonomic storms, following acute neurological insults, is problematic and remains poorly researched. This paper presents six subjects with dysautonomia following extremely severe traumatic brain injury where gabapentin controlled paroxysmal autonomic changes and posturing in the early post-acute phase following limited success with conventional medication regimens. In two subjects, other medications were reduced or ceased without a recurrence of symptoms. It is proposed that medications that can block or minimise abnormal afferent stimuli may represent a better option for dysautonomia management than drugs which increase inhibition of efferent pathways. Potential mechanisms for these effects are discussed.


Abbreviations: ANS, autonomic nervous system; ITB, intrathecal baclofen; TBI, traumatic brain injury







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.